2m 2m 2m 2m 2m 2m 2m
Pacific Bio CA (PACB)
NASDAQ
$1.50+$0.007 (+0.47%)
Price as of Jul 14, 2026 4:11 AM EDT- $484.5MMarket Cap
- 2.05%1-Year Change
- Medical DevicesIndustry
Pacific Bio CA (PACB)
$1.50+$0.007 (+0.47%)
PACB | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.49 | ||
Change | -$0.07 (-4.49%) | ||
Open | $1.53 | ||
High | $1.56 | ||
Low | $1.47 | ||
Previous Close | $1.56 | ||
Volume | 5,397,032 | ||
30-Day Average Volume | 6,268,795 | ||
1-Week Change | -10.24% | ||
1-Month Change | 13.74% | ||
1-Year Change | 2.05% | ||
3-Year Change | -89.27% | ||
5-Year Change | -94.98% | ||
Fundamentals | |||
Shares Outstanding | 310.6M | ||
Total Assets | $782.4M | ||
Market Cap | $484.5M | ||
Enterprise Value | $1.1B | ||
Period: QTR TTM FY | |||
Revenue | $31.5M | ||
Net Income | -$8.3M | ||
Free Cash Flow | -$47.7M | ||
EBIT | -$6.3M | ||
EBITDA | -$5.3M | ||
Net Working Capital | $304.2M | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | -202 | ||
Enterprise Value/Revenue | 34 | ||
P/B | 205 | ||
P/E | -52 | ||
PEG | -1 | ||
Price/Free Cash Flow | -10 | ||
Price/Operating Cash Flow | -11 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue